Cardiovascular magnetic resonance late gadolinium enhancement risk score for mortality in hypertrophic cardiomyopathy: the HCM-LGE risk score

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Jeremy Florence

Hospital Lariboisiere, Paris (France)

5 More presentations in this session

Presentation thumbnail

Assessment of left ventricular function measured with cardiac MRI feature tracking predicts heart failure events in childhood hypertrophic cardiomyopathy

Doctor X. Chen (Beijing, CN)

Abstract Slides

Presentation thumbnail

CMR-based assessment of left ventricular hemodynamics in obstructive hypertrophic cardiomyopathy treated with septal reduction therapy

Ms M. Yu (Sichuan, CN)

Abstract Slides

Presentation thumbnail

The PA/Ao ratio as a predictor for adverse outcomes in light-chain vs. transthyretin cardiac amyloidosis

Mr L. List (Vienna, AT)

Abstract Slides

Presentation thumbnail

Novel thresholds for all-cause mortality risk stratification in hypertrophic cardiomyopathy using cardiac magnetic resonance- late gadolinium enhancement

Miss S. Arshanapalli (London, GB)

Abstract Slides

Presentation thumbnail

Comprehensive cardiovascular magnetic resonance for evaluating structural myocardial changes in patients with hypertrophic obstructive cardiomyopathy treated with the first myosin inhibitor

Doctor L. Seuthe (Cologne, DE)

Abstract Slides

Access the full session

Session thumbnail

Prognostic imaging in hypertrophic cardiomyopathy and amyloidosis

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

CMR in acute coronary syndrome: optional or essential? - discussion

Congress Presentation

Late gadolinium enhancement and viability

Congress Presentation

Magnetic resonance imaging is the way to go for risk assessment

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources